{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:14:55Z","timestamp":1791936895696,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd006449","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T00:00:00Z","timestamp":1239753600000}}],"reference-count":34,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006449.pub2","type":"journal-article","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T15:09:55Z","timestamp":1239808195000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Antistaphylococcal immunoglobulins to prevent staphylococcal infection in very low birth weight infants"],"prefix":"10.1002","volume":"2010","author":[{"given":"Prakeshkumar S","family":"Shah","sequence":"first","affiliation":[{"name":"University of Toronto; Department of Paediatrics and Department of Health Policy, Management and Evaluation, Rm 775A; 600 University Avenue Toronto Ontario Canada M5G 1XB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Kaufman","sequence":"additional","affiliation":[{"name":"University of Virginia School of Medicine; Pediatrics; Charlottesville Virginia USA 22908"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,15]]},"reference":[{"key":"10.1002\/14651858.CD006449.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.jp.7211496","article-title":"A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin","volume":"26","author":"Benjamin","year":"2006","journal-title":"Journal of Perinatology"},{"issue":"10","key":"10.1002\/14651858.CD006449.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/01.inf.0000180504.66437.1f","article-title":"Multicenter study to assess safety and efficacy of INH-A21, a donor-selected human staphylococcal immunoglobulin, for prevention of nosocomial infections in very low birth weight infants","volume":"24","author":"Bloom","year":"2005","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jpeds.2007.04.060","article-title":"Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants","volume":"151","author":"DeJonge","year":"2007","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1128\/AAC.49.10.4121-4127.2005","article-title":"Multicenter study to determine antibody concentrations and assess the safety of administration of INH-A21, a donor-selected human Staphylococcal immune globulin, in low-birth-weight infants","volume":"49","author":"Capparelli","year":"2005","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0005|cit5","first-page":"4","article-title":"Safety of a Staphylococcus Aureus (SA) Intravenous Human Immune Globulin (AltaStaph) in Very-Low-Birth-Weight (VLBW) Neonates","volume":"47","author":"Mandy","year":"2000","journal-title":"Pediatric Research"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0006|cit6","first-page":"3724.6","article-title":"Phase II Randomized, Double Blind, Placebo-Controlled, Safety, Pharmacokinetics (PK), and Clinical Activity Study in Very Low Birth Weight (VLBW) Neonates of Pagibaximab, a Monoclonal Antibody for the Prevention of Staphylococcal Infection","volume":"59","author":"Thackray","year":"2006","journal-title":"Pediatric Research E-PAS"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0007|cit7","article-title":"Safety and Pharmacokinetics of a Human Chimeric Anti-Staphylococcal Monoclonal Antibody for Prevention of Coagulase Negative Staphylococcal Infection in Very Low Birth Weight Infants: Preliminary Report","volume":"53","author":"Weisman","year":"2003","journal-title":"Pediatric Research"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0008|cit8","first-page":"4","article-title":"Phase I\/II Double Blind, Placebo Controlled, Dose Escalation, Safety and Pharmacokinetics Study in Very Low Birth Weight Neonates of BSYX-A110, an Anti-Staphylococcal Monoclonal Antibody for the Prevention of Staphylococcal Bloodstream Infections","volume":"55","author":"Weisman","year":"2004","journal-title":"Pediatric Research"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/01.qco.0000224825.57976.87","article-title":"Neonatal infection and long-term neurodevelopmental outcome in the preterm infant","volume":"19","author":"Adams-Chapman","year":"2006","journal-title":"Current Opinion in Infectios Diseases"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/siny.2002.0116","article-title":"The current role of colony-stimulating factors in prevention and treatment of neonatal sepsis","volume":"7","author":"Banerjea","year":"2002","journal-title":"Seminars in Neonatology"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000658-197801000-00001","article-title":"Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging","volume":"187","author":"Bell","year":"1978","journal-title":"Annals of Surgery"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1128\/AAC.49.10.4121-4127.2005","article-title":"Multicenter study to determine antibody concentrations and assess the safety of administration of INH-A21, a donor-selected human Staphylococcal immune globulin, in low-birth-weight infants","volume":"49","author":"Capparelli","year":"2005","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD006449.pub2-BIB0013|cit13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001150.pub2","article-title":"Topical ointment for preventing infection in preterm infants","author":"Conner","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00006454-199807000-00004","article-title":"Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network","volume":"17","author":"Fanaroff","year":"1998","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.ajog.2004.06.058","article-title":"Neonatal cerebral white matter injury in preterm infants is associated with culture positive infections and only rarely with metabolic acidosis","volume":"191","author":"Graham","year":"2004","journal-title":"American Journal of Obstetric and Gynecology"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1542\/peds.95.2.225","article-title":"Coagulase-negative staphylococcal bacteremia among very low birth weight infants: relation to admission illness severity, resource use, and outcome","volume":"95","author":"Gray","year":"1995","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1542\/peds.107.1.14","article-title":"Collaborative quality improvement for neonatal intensive care. NIC\/Q Project Investigators of the Vermont Oxford Network","volume":"107","author":"Horbar","year":"2001","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1128\/CMR.17.3.638-680.2004","article-title":"Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants","volume":"17","author":"Kaufman","year":"2004","journal-title":"Clinical Microbiological Review"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0019|cit19","first-page":"172","article-title":"Veronate (Inhibitex)","volume":"7","author":"Kaufman","year":"2006","journal-title":"Current Opinion on Investigational Drugs"},{"issue":"1","key":"10.1002\/14651858.CD006449.pub2-BIB0020|cit20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001239.pub2","article-title":"Intravenous immunoglobulin for suspected or subsequently proven infection in neonates","author":"Ohlsson","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006449.pub2-BIB0021|cit21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000361.pub2","article-title":"Intravenous immunoglobulin for preventing infection in preterm and\/or low-birth-weight infants","author":"Ohlsson","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","article-title":"Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm","volume":"92","author":"Papile","year":"1978","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/039139880502801113","article-title":"Vaccines and immunotherapy for staphylococcal infections","volume":"28","author":"Patti","year":"2005","journal-title":"International Journal of Artificial Organs"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1749-6632.1995.tb55834.x","article-title":"Developmental regulation of the human antibody repertoire","volume":"764","author":"Schroeder","year":"1995","journal-title":"Annals of New York Academy of Science"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1542\/peds.82.4.527","article-title":"Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period","volume":"82","author":"Shennan","year":"1988","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/adc.2005.078733","article-title":"A prospective study of the immediate and delayed adverse events following intravenous immunoglobulin infusions","volume":"91","author":"Singh-Grewal","year":"2006","journal-title":"Archives of Disease of Childhood"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1172\/JCI115029","article-title":"Delineation of the functional capacity of human neonatal lymphocytes","volume":"87","author":"Splawski","year":"1991","journal-title":"Journal of Clinical Investigations"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1542\/peds.110.2.285","article-title":"Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network","volume":"110","author":"Stoll","year":"2002","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1001\/jama.292.19.2357","article-title":"Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection","volume":"292","author":"Stoll","year":"2004","journal-title":"Journal of the American Medical Association"},{"issue":"4","key":"10.1002\/14651858.CD006449.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/QCO.0b013e3281a7ec98","article-title":"Neonatal immune responses to coagulase-negative staphylococci","volume":"20","author":"Strunk","year":"2007","journal-title":"Current Opinion in Infectious Diseases"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1128\/AAC.50.2.511-518.2006","article-title":"Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo","volume":"50","author":"Vernachio","year":"2006","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/00006454-199412000-00010","article-title":"Opsonic activity of commercially available standard intravenous immunoglobulin preparations","volume":"13","author":"Weisman","year":"1994","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00001432-200406000-00011","article-title":"Coagulase-negative staphylococcal disease: emerging therapies for the neonatal and pediatric patient","volume":"17","author":"Weisman","year":"2004","journal-title":"Current Opinion in Infectious Diseases"},{"key":"10.1002\/14651858.CD006449.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0929-693X(07)80008-X","article-title":"Antibody for teh prevention of neonatal nosocomial staphylococcal infection: a review of the literature","volume":"14","author":"Weisman","year":"2007","journal-title":"Archives de Pediatrie"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD006449.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T11:02:02Z","timestamp":1755687722000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006449.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Neonatal Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,4,15]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006449.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,15]]}}}